- Home
- HDSN vs NBP Comparison
HDSN vs NBP Comparison
Compare HDSN & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HDSN | NBP |
|---|---|---|
| Founded | 1991 | 2014 |
| Country | United States | United States |
| Employees | N/A | 30 |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 239.9M | 212.8M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | HDSN | NBP |
|---|---|---|
| Price | $5.50 | $1.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $9.00 | $9.00 |
| AVG Volume (30 Days) | 594.2K | ★ 818.5K |
| Earning Date | 05-06-2026 | 04-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $237,118,000.00 | N/A |
| Revenue This Year | $2.51 | N/A |
| Revenue Next Year | $2.38 | N/A |
| P/E Ratio | $527.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.64 | $1.63 |
| 52 Week High | $10.52 | $5.19 |
Technical Indicators
Market Signals| Indicator | HDSN | NBP |
|---|---|---|
| Relative Strength Index (RSI) | 51.94 | 35.76 |
| Support Level | $4.64 | $1.67 |
| Resistance Level | $6.49 | $1.95 |
| Average True Range (ATR) | 0.21 | 0.11 |
| MACD | 0.07 | 0.02 |
| Stochastic Oscillator | 96.07 | 52.38 |
Price Performance
Historical ComparisonAbout HDSN Hudson Technologies Inc.
Hudson Technologies Inc is an American industrial products manufacturer. It develops products which are mainly used in commercial air conditioning, industrial processing, and refrigeration systems. The company products include refrigerant and industrial gases, refrigerant management services and RefrigerantSide services, which consist of system decontamination. These are performed at customer's site using its Zugibeast system, which is a fast and portable system and allows the R-Side services team to accelerate critical services while saving customers time, money and aggravation. The company also owns a web-based real-time monitoring service which is used in the facility's refrigeration systems and other energy systems.
About NBP NovaBridge Biosciences American Depositary Shares
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.